High-Density Lipoprotein — The Clinical Implications of Recent Studies

High density lipoprotein as a protective factor against coronary heart disease

Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059 · see citing works

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · see citing works

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162 · see citing works

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621 · see citing works

The plasma lecithin:cholesterol acyltransferase reaction

Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,409 · see citing works

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study

Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,305 · see citing works

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,292 · see citing works

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824 · see citing works

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654 · see citing works

Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels

Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,620 · see citing works

Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.

Mattson, F. H., & Grundy, S. M. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34389-3 · Cited by 1,354 · see citing works

High density lipoprotein metabolism.

Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212 · see citing works

THE TROMSØHEART-STUDY

Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206 · see citing works

Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study

Manninen, V. (1988) · JAMA · doi:10.1001/jama.1988.03410050061031 · Cited by 954 · see citing works

The Role of Lipids and Lipoproteins in Atherosclerosis

Gofman, J. W., Lindgren, F. T., Elliott, H. A., Mantz, W., Hewitt, J. E., Strisower, B., Herring, V. V., & Lyon, T. P. (1950) · Science · doi:10.1126/science.111.2877.166 · Cited by 921 · see citing works

Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

Rhoads, G. G., Gulbrandsen, C. L., & Kagan, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940601 · Cited by 876 · see citing works

Lipoprotein metabolism in diabetes mellitus.

Howard, B. V. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38659-4 · Cited by 640 · see citing works

Protein-lipid relationships in human plasma

Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635 · see citing works

Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis

Arntzenius, A. C., Kromhout, D., Barth, J. D., Reiber, J. H. C., Bruschke, A. V. G., Buis, B., van Gent, C. M., Kempen-Voogd, N., Strikwerda, S., & van der Velde, E. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121301 · Cited by 498 · see citing works

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90638-7 · Cited by 468 · see citing works

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

Levy, R. I., Brensike, J. F., Epstein, S. E., Kelsey, S. F., Passamani, E. R., Richardson, J. M., Loh, I. K., Stone, N. J., Aldrich, R. F., & Battaglini, J. W. (1984) · Circulation · doi:10.1161/01.cir.69.2.325 · Cited by 437 · see citing works

Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions

Godsland, I. F., Wynn, V., Crook, D., & Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90552-7 · Cited by 322 · see citing works

Contractile performance of the hypertrophied ventricle in patients with systemic hypertension.

Takahashi, M., Sasayama, S., Kawai, C., & Kotoura, H. (1980) · Circulation · doi:10.1161/01.cir.62.1.116 · Cited by 302 · see citing works

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.

Gordon, D. J., Knoke, J. D., Probstfield, J. L., Superko, H. R., & Tyroler, H. A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1217 · Cited by 289 · see citing works

High density lipoprotein distribution

Anderson, D. W., Nichols, A. V., Pan, S., & Lindgren, F. T. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90005-9 · Cited by 283 · see citing works

Estrogen Use and All-Cause Mortality

Bush, T. L. (1983) · JAMA · doi:10.1001/jama.1983.03330310033022 · Cited by 280 · see citing works

Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries

Simons, L. A. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90659-4 · Cited by 229 · see citing works

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency.

Schaefer, E. J. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.4.303 · Cited by 174 · see citing works

Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.

Goldbourt, U., Holtzman, E. J., & Neufeld, H. N. (1985) · BMJ · doi:10.1136/bmj.290.6477.1239 · Cited by 170 · see citing works

Plasma High-Density Lipoprotein Cholesterol Level

Hulley, S. B. (1977) · JAMA · doi:10.1001/jama.238.21.2269 · Cited by 167 · see citing works

Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake.

Knuiman, J. T., West, C. E., Katan, M., & Hautvast, J. G. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.6.612 · Cited by 146 · see citing works

DNA polymorphisms of the apolipoprotein genes — their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis

Humphries, S. E. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90069-x · Cited by 139 · see citing works

High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

Pocock, S., Shaper, A. G., Phillips, A. N., Walker, M., & Whitehead, T. P. (1986) · BMJ · doi:10.1136/bmj.292.6519.515 · Cited by 127 · see citing works

Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the multiple risk factor intervention trial

Watkins, L. O., Neaton, J. D., & Kuller, L. H. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90831-3 · Cited by 112 · see citing works

ALPHA LIPOPROTEIN (HDL) CHOLESTEROL IN THE SERUM AND THE RISK OF CORONARY HEART DISEASE AND DEATH

Keys, A. B. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90280-9 · Cited by 111 · see citing works

Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample The Framingham offspring study

Anderson, K. M., Wilson, P. W. F., Garrison, R. J., & Castelli, W. P. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90094-3 · Cited by 108 · see citing works

Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain.

Thorogood, M., Carter, R., Benfield, L., McPherson, K., & Mann, J. I. (1987) · BMJ · doi:10.1136/bmj.295.6594.351 · Cited by 107 · see citing works

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

Enger, S. C., Hjermann, I., FOSS, O. P., Helgeland, A., Holme, I., Leren, P., & Norum, K. R. (1979) · PubMed · Cited by 98 · see citing works

Hyperalpha- and hypobeta-lipoproteinemia in octogenarian kindreds

Glueck, C. J., Gartside, P. S., Steiner, P. M., Miller, M., Todhunter, T., ten Haaf, J., Pucke, M., Terrana, M., Fallat, R. W., & Kashyap, M. L. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90159-9 · Cited by 76 · see citing works

HDL Serum Cholesterol and 24–Year Mortality of Men in Finland

Keys, A. B., KARVONEN, M. J., Punsar, S., Menotti, A., Fidanza, F., & Farchi, G. (1984) · International Journal of Epidemiology · doi:10.1093/ije/13.4.428 · Cited by 74 · see citing works

Letter: No childhood.

Sheridan, M. D. (1975) · PubMed · doi:10.1016/s0140-6736(75)90187-7 · Cited by 73 · see citing works

Plasma Lipoprotein Levels in Vegetarians

Sacks, F. M. (1985) · JAMA · doi:10.1001/jama.254.10.1337 · Cited by 72 · see citing works

Apolipoprotein A-I, A-II and C-II in black and white residents of Evans County.

Tyroler, H. A., HEISS, G. M., Schonfeld, G., Cooper, G. R., Heyden, S., & Hames, C. G. (1980) · Circulation · doi:10.1161/01.cir.62.2.249 · Cited by 67 · see citing works

High density lipoprotein subfractions and coronary risk factors in normal men.

Robinson, D., Ferns, G., Bevan, E. A., Stocks, J., Williams, P. T., & Galton, D. J. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.4.341 · Cited by 65 · see citing works

Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men

Wiklund, O., Wilhelmsen, L., Elmfeldt, D., Wedel, H., Válek, J., & Gustafson, A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90092-1 · Cited by 34 · see citing works

High-density lipoprotein cholesterol measurements. A help or hindrance in practical clinical medicine?

Superko, H. R. (1986) · JAMA · doi:10.1001/jama.256.19.2714 · Cited by 30 · see citing works

DIET, OTHER LIFESTYLE FACTORS AND HDL CHOLESTEROL IN A POPULATION OF AUSTRALIAN MALE SERVICE RECRUITS

Dwyer, T., Calvert, G. D., Baghurst, K. I., & LEITCH, D. R. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113239 · Cited by 22 · see citing works

Gemfibrozil, Lipids, and Coronary Risk

Rifkind, B. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172008 · Cited by 17 · see citing works

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880 · see citing works

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · see citing works

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works

Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials

Mensink, R. P., & Katan, M. B. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.8.911 · Cited by 1,477 · see citing works

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI

Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. (1991) · Nature · doi:10.1038/353265a0 · Cited by 985 · see citing works

Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931 · see citing works

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942 · see citing works

Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation

Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 862 · see citing works

A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism

Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 859 · see citing works

The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors: A Randomized Trial

Covas, M.-I., Nyyssönen, K., Poulsen, H. E., Kaikkonen, J., Zunft, H.-J. F., Kiesewetter, H., Gaddi, A., de la Torre, R., Mursu, J., Bäumler, H., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-5-200609050-00006 · Cited by 758 · see citing works

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

Yuhanna, I. S., Zhu, Y., Cox, B. E., Hahner, L., Osborne-Lawrence, S. L., Lu, P., Marcel, Y. L., Anderson, R. G. W., Mendelsohn, M. E., Hobbs, H. H., et al. (2001) · Nature Medicine · doi:10.1038/89986 · Cited by 742 · see citing works

Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States

Ascherio, A., Rimm, E. B., Giovannucci, E. L., Spiegelman, D. L., Stampfer, M. J., & Willett, W. C. (1996) · BMJ · doi:10.1136/bmj.313.7049.84 · Cited by 732 · see citing works

ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation

Yvan‐Charvet, L., Pagler, T. A., Gautier, E. L., Avagyan, S., Siry, R., Han, S., Welch, C. L., Wang, N., Randolph, G. J., Snoeck, H. W., et al. (2010) · Science · doi:10.1126/science.1189731 · Cited by 724 · see citing works

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

Kozarsky, K., Donahee, M. H., Rigotti, A., Iqbal, S. N., Edelman, E. R., & Krieger, M. (1997) · Nature · doi:10.1038/387414a0 · Cited by 697 · see citing works

Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux

Ji, Y. I., Jian, B., Wang, N., Sun, Y., Moya, M. D. L. L., Phillips, M. C., Rothblat, G. H., Swaney, J. B., & Tall, A. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20982 · Cited by 694 · see citing works

High Density Lipoproteins and Arteriosclerosis

von Eckardstein, A., Nofer, J., & Assmann, G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 696 · see citing works

Macrophage phenotypes in atherosclerosis

Colin, S., Chinetti‐Gbaguidi, G., & Staels, B. (2014) · Immunological Reviews · doi:10.1111/imr.12218 · Cited by 657 · see citing works

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

Levine, G., Keaney, J., & Vita, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320807 · Cited by 702 · see citing works

Endothelial and Antithrombotic Actions of HDL

Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 650 · see citing works

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 650 · see citing works

HDL Cholesterol and Protective Factors in Atherosclerosis

Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 630 · see citing works

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380203 · Cited by 623 · see citing works

Protein-Based Nanoparticles as Drug Delivery Systems

Hong, S., Choi, D. W., Kim, H. N., Park, C. G., Lee, W., & Park, H. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070604 · Cited by 623 · see citing works

Healthy Traditional Mediterranean Diet: An Expression of Culture, History, and Lifestyle

Trichopoulou, A., & Λάγιου, Π. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1997.tb01578.x · Cited by 614 · see citing works

HDL and arteriosclerosis: beyond reverse cholesterol transport

Nofer, J., Kehrel, B. E., Fobker, M., Levkau, B., Assmann, G., & von Eckardstein, A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 594 · see citing works

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

Zhong, S., Sharp, D. S., Grove, J., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 582 · see citing works

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

Plump, A. S., Scott, C., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 569 · see citing works

Regulation of Endothelial Nitric Oxide Synthase: Location, Location, Location

Shaul, P. W. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155952 · Cited by 541 · see citing works

Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study

Leng, G. C., Fowkes, F. G. R., Alexander, L. E. E., Dunbar, J., Housley, E., & Ruckley, C. V. (1996) · BMJ · doi:10.1136/bmj.313.7070.1440 · Cited by 525 · see citing works

Charting the Fate of the “Good Cholesterol”: Identification and Characterization of the High-Density Lipoprotein Receptor SR-BI

Krieger, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.523 · Cited by 517 · see citing works

Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology

Trigatti, B. L., Rayburn, H., Viñals, M., Braun, A., Miettinen, H. E., Penman, M., Hertz, M., Schrenzel, M. D., Amigo, L., Rigotti, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9322 · Cited by 504 · see citing works

A novel endothelial-derived lipase that modulates HDL metabolism

Jaye, M., Lynch, K. J., Krawiec, J. A., Marchadier, D. H. L., Maugeais, C., Doan, K. N., South, V., Amin, D., Perrone, M. H., & Rader, D. J. (1999) · Nature Genetics · doi:10.1038/7766 · Cited by 499 · see citing works

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works

In vivo protection against endotoxin by plasma high density lipoprotein.

Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485 · see citing works

Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study

Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476 · see citing works

Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease.

Sacks, F., & Katan, M. (2002) · American Journal of Medicine · doi:10.1016/s0002-9343(01)00987-1 · Cited by 523 · see citing works

Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women

Liu, S., Manson, J. E., Stampfer, M. J., Holmes, M. D., Hu, F. B., Hankinson, S. E., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.3.560 · Cited by 454 · see citing works

Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages

Yvan‐Charvet, L., Welch, C. L., Pagler, T. A., Ranalletta, M., Lamkanfi, M., Han, S., Ishibashi, M., Li, R., Wang, N., & Tall, A. R. (2008) · Circulation · doi:10.1161/circulationaha.108.793869 · Cited by 456 · see citing works

Dietarytrans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women

Judd, J., Clevidence, B., Muesing, R. A., Wittes, J. T., Sunkin, M. E., & Podczasy, J. J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.861 · Cited by 457 · see citing works

Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans.

Zock, P. L., & Katan, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41530-5 · Cited by 440 · see citing works

The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues

Rigotti, A., Miettinen, H. E., & Krieger, M. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0037 · Cited by 435 · see citing works

Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome

Risérus, U., Arner, P., Brismar, K., & Vessby, B. O. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1516 · Cited by 435 · see citing works

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism

Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417 · see citing works

Perspectives and opportunities for nanomedicine in the management of atherosclerosis

Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423 · see citing works

High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P 3 Lysophospholipid Receptor

Theilmeier, G., Schmidt, C., Herrmann, J., Keul, P., Schäfers, M. A., Herrgott, I., Mersmann, J., Larmann, J., Hermann, S., Stypmann, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.607135 · Cited by 414 · see citing works

Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins

Khovidhunkit, W., Memon, R. A., Feingold, K. R., & Grünfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403 · see citing works

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

Drew, B. G., Duffy, S. J., Formosa, M. F., Natoli, A. K., Henstridge, D. C., Penfold, S. A., Thomas, W. G., Mukhamedova, N., de Courten, B., Forbes, J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843219 · Cited by 443 · see citing works

High-Density Lipoprotein as a Therapeutic Target: A Systematic Review

Singh, I. M., Shishehbor, M. H., & Ansell, B. J. (2007) · JAMA · doi:10.1001/jama.298.7.786 · Cited by 468 · see citing works

Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL

Zannis, V. I., Chroni, A., & Krieger, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0030-4 · Cited by 391 · see citing works

High Density Lipoprotein-induced Endothelial Nitric-oxide Synthase Activation Is Mediated by Akt and MAP Kinases

Mineo, C., Yuhanna, I. S., Quon, M. J., & Shaul, P. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211394200 · Cited by 390 · see citing works

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

Frick, M., Syvänne, M., Nieminen, M., Kauma, H., Majahalme, S., Virtanen, V., Kesäniemi, Y., Pasternack, A., & Taskinen, M. R. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 409 · see citing works

Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk

Ordovás, J. M., Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D. P., Martinez, A. A., Lahoz, C., Coltell, Ó., Wilson, P. W. F., & Schaefer, E. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1323 · Cited by 379 · see citing works

The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis

Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 377 · see citing works

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

Pászty, C., Maeda, N., Verstuyft, J. G., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 375 · see citing works

Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids

Nofer, J., Levkau, B., Wolinska, I., Junker, R., Fobker, M., von Eckardstein, A., Seedorf, U., & Assmann, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103782200 · Cited by 358 · see citing works

Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice

Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D. C., Puré, E., & Rader, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.17.1816 · Cited by 357 · see citing works

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

Uusitupa, M. I. J., NISKANEN, L. K., Siitonen, O., Voutilainen, E., & Py�r�l�, K. (1993) · Diabetologia · doi:10.1007/bf00401063 · Cited by 353 · see citing works

Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45

Blatter, M.-C., James, R. W., Messmer, S., Barja, F., & Pometta, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347 · see citing works

Apolipoprotein-mediated removal of cellular cholesterol and phospholipids

Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 342 · see citing works

High-density lipoproteins: A consensus statement from the National Lipid Association

Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336 · see citing works

Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor–Deficient Mouse

Kozarsky, K., Donahee, M. H., Glick, J. M., Krieger, M., & Rader, D. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.721 · Cited by 337 · see citing works

Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice

Chen, Z., Ishibashi, S., Perrey, S., Osuga, J.-I., Gotoda, T., Kitamine, T., Tamura, Y., Okazaki, H., Yahagi, N., Iizuka, Y., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.372 · Cited by 320 · see citing works

HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells

Feig, J. E., Rong, J. X., Shamir, R., Sanson, M., Vengrenyuk, Y., Liu, J., Rayner, K. J., Moore, K. J., Garabedian, M. J., & Fisher, E. A. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016086108 · Cited by 313 · see citing works

Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

Rittershaus, C. W., MILLER, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H. Y., Hammond, R. A., Beattie, D. T., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2106 · Cited by 308 · see citing works

The emerging role of HDL in glucose metabolism

Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307 · see citing works

Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol

Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4619 · Cited by 303 · see citing works

Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase

Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., Shimizugawa, T., Ando, Y., Koishi, R., Kohama, T., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000252827.51626.89 · Cited by 297 · see citing works

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.

Laakso, M., Lehto, S., Penttilä, I., & Pyörälà, K. (1993) · Circulation · doi:10.1161/01.cir.88.4.1421 · Cited by 301 · see citing works

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.

Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D., & Marques-Vidal, P. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118207 · Cited by 300 · see citing works

STATISTICAL METHODS FOR THE ANALYSIS OF HIGH-THROUGHPUT METABOLOMICS DATA

Bartel, J., Krumsiek, J., & Theis, F. J. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201301009 · Cited by 297 · see citing works

Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice

Agellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X., Shelanski, S. A., Breslow, J. L., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99088-5 · Cited by 295 · see citing works

The Critical Role of Mast Cells in Allergy and Inflammation

Theoharides, T. C., & Kalogeromitros, D. C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.025 · Cited by 291 · see citing works

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

Bloedon, L. T., Dunbar, R. L., Duffy, D., Pinell-Salles, P., Norris, R., DeGroot, B. J., Movva, R., Navab, M., Fogelman, A. M., & Rader, D. J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.p800003-jlr200 · Cited by 290 · see citing works

Restoration of Endothelial Function by Increasing High-Density Lipoprotein in Subjects With Isolated Low High-Density Lipoprotein

Bisoendial, R. J., Hovingh, G. K., Levels, J. H. M., Lerch, P. G., Andresen, I., Hayden, M. R., Kastelein, J. J. P., & Stroes, E. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000070934.69310.1a · Cited by 287 · see citing works

High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I

Seetharam, D., Mineo, C., Gormley, A. K., Gibson, L. L., Vongpatanasin, W., Chambliss, K. L., Hahner, L., Cummings, M. L., Kitchens, R. L., Marcel, Y. L., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000199272.59432.5b · Cited by 282 · see citing works

HMG-CoA Reductase Inhibitors and Myotoxicity

Ucar, M., Mjörndal, T., & Dahlqvist, R. (2000) · Drug Safety · doi:10.2165/00002018-200022060-00003 · Cited by 279 · see citing works

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Institute of Medicine (2010) · National Academies Press eBooks · doi:10.17226/12869 · Cited by 273 · see citing works

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Krishna, R., Anderson, M. S., Bergman, A. J., Jin, B., Fallon, M. S., Côté, J., Rosko, K., Chavez-Eng, C. M., Lutz, R., Bloomfield, D. M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61813-3 · Cited by 275 · see citing works

Liver-specific Overexpression of Scavenger Receptor BI Decreases Levels of Very Low Density Lipoprotein ApoB, Low Density Lipoprotein ApoB, and High Density Lipoprotein in Transgenic Mice

Wang, N., Arai, T., Ji, Y. I., Rinninger, F., & Tall, A. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32920 · Cited by 275 · see citing works

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

Joyce, C. W., Amar, M. J., Lambert, G. C., Vaisman, B. L., Paigen, B. J., Najib-Fruchart, J., Hoyt, R. F., Neufeld, E. D., Remaley, A. T., Fredrickson, D. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012587699 · Cited by 269 · see citing works

Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.

Hayek, T., Masucci-Magoulas, L., Jiang, X. L., Walsh, A., Rubin, E. M., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118255 · Cited by 266 · see citing works

Hepatic Scavenger Receptor BI Promotes Rapid Clearance of High Density Lipoprotein Free Cholesterol and Its Transport into Bile

Ji, Y. I., Wang, N., Ramakrishnan, R., Sehayek, E., Huszar, D., Breslow, J. L., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33398 · Cited by 263 · see citing works

Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis.

Zeiher, A. M., Schächlinger, V., Hohnloser, S. H., Saurbier, B., & Just, H. (1994) · Circulation · doi:10.1161/01.cir.89.6.2525 · Cited by 258 · see citing works

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Inazu, A., Jiang, X., Haraki, T., Yagi, K., KAMON, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K., & Moriyama, Y. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117537 · Cited by 246 · see citing works

Could targeted food taxes improve health?

Mytton, O. T., Gray, A. M., Rayner, M., & Rutter, H. (2007) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.047746 · Cited by 244 · see citing works

The impact of phospholipid transfer protein (PLTP) on HDL metabolism

Huuskonen, J., Olkkonen, V. M., Jauhiainen, M., & Ehnholm, C. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00447-6 · Cited by 243 · see citing works

Endothelial Protection by High-Density Lipoproteins

Calabresi, L., Gomaraschi, M., & Franceschini, G. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000094961.74697.54 · Cited by 242 · see citing works

Differential Effects of Scavenger Receptor BI Deficiency on Lipid Metabolism in Cells of the Arterial Wall and in the Liver

Eck, M. V., Twisk, J., Hoekstra, M., Rij, B. T. V., van der Lans, C. A. C., Bos, I. S. T., Kruijt, J. K., Kuipers, F., & van Berkel, T. J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211233200 · Cited by 238 · see citing works

Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice

Shah, P. K., Nilsson, J. Å., Kaul, S., Fishbein, M. C., Ageland, H., Hamsten, A., Johansson, J., Karpe, F., & Cercek, B. (1998) · Circulation · doi:10.1161/01.cir.97.8.780 · Cited by 238 · see citing works

Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion

Brousseau, M. E., Diffenderfer, M. R., Millar, J. S., Nartsupha, C., Asztalos, B. F., Welty, F. K., Wolfe, M. L., Rudling, M. J., Björkhem, I., Angelin, B., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000161928.16334.dd · Cited by 229 · see citing works

Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1

Cavelier, C., Lorenzi, I., Rohrer, L., & von Eckardstein, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.012 · Cited by 232 · see citing works

Structural models of human apolipoprotein A-I: a critical analysis and review

Brouillette, C. G., Anantharamaiah, G. M., Engler, J. A., & Borhani, D. W. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00081-6 · Cited by 232 · see citing works

ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet

Terasaka, N., Yu, S., Yvan‐Charvet, L., Wang, N., Mzhavia, N., Langlois, R., Pagler, T. A., Li, R., Welch, C. L., Goldberg, I. J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35470 · Cited by 232 · see citing works

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

Hoeg, J. M., Santamarina-Fojo, S., Bérard, A. M., Cornhill, J. F., Herderick, E. E., Feldman, S. H., Haudenschild, C. C., Vaisman, B. L., Hoyt, R. F., Demosky, S. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11448 · Cited by 230 · see citing works

The role of hepatic lipase in lipoprotein metabolism and atherosclerosis

Santamarina-Fojo, S., Haudenschild, C., & Amar, M. J. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00005 · Cited by 229 · see citing works

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

Curb, J. D., Abbott, R. D., Rodríguez, B. L., Masaki, K., Chen, R., Sharp, D. S., & Tall, A. R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300520-jlr200 · Cited by 228 · see citing works

Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk

Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227 · see citing works

Novel Biological Functions of High-Density Lipoprotein Cholesterol

Mineo, C., & Shaul, P. W. (2012) · Circulation Research · doi:10.1161/circresaha.111.258673 · Cited by 228 · see citing works

Prevalence of risk factors in men with premature coronary artery disease

Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90924-a · Cited by 243 · see citing works

Recent advance on high-density lipoprotein and its protection of cardiovascular disease

Wang, X. (2012) · Chinese Heart Journal

High Density Lipoproteins: An Overview

Castelli, W. P. (1980) · Springer eBooks · doi:10.1007/978-1-4612-6071-4_94 · Cited by 25 · see citing works

HDL as a Risk Factor for Coronary Heart Disease: An Update on the Helsinki Heart Study

Mänttäri, M., & Manninen, V. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_41

Dusty punch cards and an eternal enigma: high-density lipoproteins and atherosclerosis

Kleber, M. E., Grammer, T. B., Kassner, U., Silbernagel, G., & März, W. (2014) · Open Access CRIS of the University of Bern · doi:10.7892/boris.54478

The Low-HDL Syndrome: Epidemiology and Pathophysiology

Franceschini, G., Villa, B., Gomaraschi, M., & Calabresi, L. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1171-7_14